Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8790007 | Urologic Oncology: Seminars and Original Investigations | 2018 | 8 Pages |
Abstract
High NORAD expression could serve as an independent prognostic factor for overall survival of patients with transitional BC. NORAD could be considered as a promising candidate for novel biomarker and therapeutic target for human BC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Qiaqia M.D., Chao Li, Jinbo M.D., Peihua Liu, Yu M.D., Xinyi Zhou, Huihuang Li, Xiongbing Zu,